TransAxon
TransAxon builds high-resolution, augmentative brain–computer interfaces that aim to expand human function and memory without injuring the brain. They combine advanced neuro‑engineering that grows a biological bridge (autogenous induced BCI) with deep learning and AI models to achieve functional integration between brain tissue and external interfaces. The company pursues a staged pathway—drug development platforms, therapeutic implants for vision and speech, and ultimately full augmentative interfaces—using minimally invasive techniques comparable to LASIK or tattoos. This is a B2B-focused neurotechnology and biotech effort that leverages neuroscience, regenerative biology, and machine learning for clinical and research customers.
TransAxon
TransAxon builds high-resolution, augmentative brain–computer interfaces that aim to expand human function and memory without injuring the brain. They combine advanced neuro‑engineering that grows a biological bridge (autogenous induced BCI) with deep learning and AI models to achieve functional integration between brain tissue and external interfaces. The company pursues a staged pathway—drug development platforms, therapeutic implants for vision and speech, and ultimately full augmentative interfaces—using minimally invasive techniques comparable to LASIK or tattoos. This is a B2B-focused neurotechnology and biotech effort that leverages neuroscience, regenerative biology, and machine learning for clinical and research customers.